Microbot Q3 Revenue Collapses to $72K; Inventory Write-Down Drives $5.8M Loss
MBOT is trading near its 52-week low of $0.93 (7.3% above the low).
Summary
Microbot's Q3 revenue dropped to $72,000 from $241,000 in Q2, with an $815,000 inventory write-down lifting the quarterly net loss to $5,842,000. Cash and marketable securities of $61,828,000 are stated to fund operations for more than twelve months.
Key Events · Earnings and Guidance · MBOT
-
Q3 Revenue Falls Sharply
Revenue was $72,000 for the three months ended September 30, 2026, down from $241,000 in Q2 2026, which the company ties to variable sales cycles, earlier value-analysis-committee engagement and summer seasonality.
-
Inventory Write-Down Hits Margins
Cost of revenues of $1,095,000 included an $815,000 inventory write-down to net realizable value; nine-month gross loss was $1,665,000 on $418,000 of revenue.
-
Losses Widen
Q3 net loss was $5,842,000 versus $3,577,000 a year earlier; nine-month net loss was $15,140,000 versus $9,678,000, with sales and marketing up to $5,257,000 from $531,000.
-
Runway Stated Above One Year
Cash, cash equivalents and marketable securities totaled $61,828,000 at September 30, 2026, and management concluded available funds are sufficient for more than twelve months.
Analysis · MBOT · Industrial Applications And Services
The commercial ramp has stalled: revenue fell to $72,000 in Q3 from $241,000 in Q2, and cost of revenues of $1,095,000 included an $815,000 inventory write-down, pushing the quarterly net loss to $5,842,000 from $3,577,000 a year earlier. Management attributes the drop to variable early sales cycles, a shift to engaging hospital value-analysis committees earlier (a four-to-six-month process) and summer seasonality, and warns cost of goods sold will keep exceeding revenue through 2026 and into 2027. The balance sheet still carries $61,828,000 of cash and marketable securities, which management says funds operations for more than twelve months, so this is a growth-execution problem rather than an immediate solvency one — but the path to a profitable LIBERTY launch now looks longer and more capital-hungry than the Q2 report suggested.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MBOT was trading at $1.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $65.7M. The 52-week trading range was $0.93 to $2.86. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.